Skip to main content
SATTVA SUKUN LIFECARE LIMITED logo

SATTVA SUKUN LIFECARE LIMITED — Investor Relations & Filings

Ticker · 539519 ISIN · INE280E01038 BSE.NS Manufacturing
Open in API
Filings indexed 10 across all filing types
Latest filing 2026-06-04 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS 539519

About SATTVA SUKUN LIFECARE LIMITED

https://www.mayukh.co.in/

Sattva Sukun Lifecare Limited is a pharmaceutical company focused on the development, manufacturing, and distribution of a wide range of healthcare products and pharmaceutical formulations. The company specializes in producing generic medicines and therapeutic solutions aimed at improving patient outcomes and accessibility to essential treatments. Its product portfolio typically includes various dosage forms such as tablets, capsules, and liquid orals, catering to diverse medical needs. Sattva Sukun Lifecare Limited emphasizes quality control and adherence to regulatory standards to ensure the safety and efficacy of its offerings. By leveraging modern manufacturing processes and a robust supply chain, the company serves healthcare providers and patients with a commitment to enhancing overall well-being and providing cost-effective medical solutions.

Recent filings

Filing Released Lang Actions
statement
Interim / Quarterly Report Classification · 90% confidence The document is the outcome of the Board Meeting under SEBI LODR Regulations, including full audited standalone financial results for the quarter and year ended March 31, 2026, with profit & loss, balance sheet, cash flows, and the Statutory Auditor’s report. It contains substantive financial statements for a period shorter than a full fiscal year (the quarter ended March 31, 2026) and is not merely an announcement of publication. Hence, it fits the definition of an Interim / Quarterly Report rather than just an earnings highlight or a full annual report. FY 2026
2026-06-04 English
Audited Result
Interim / Quarterly Report Classification · 78% confidence The document is a compliance filing under SEBI LODR Regulations 30 and 33, comprising the Board’s approval of the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2026. It includes actual financial statements (statement of profit & loss, balance sheet, cash flows), notes and the Independent Auditor’s Report. This is not just a highlights‐only earnings release, nor a full annual report (10-K). It is a comprehensive financial report for a period shorter than a full fiscal year (the quarter ended March 31, 2026) with substantive financial data. Therefore, it best matches the “Interim / Quarterly Report (IR)” category. FY 2026
2026-06-04 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 92% confidence The document is an official board meeting outcome filed under SEBI Listing Regulations 30 and 33, announcing and providing the audited standalone financial results for the quarter and year ended March 31, 2026, complete with profit & loss, balance sheet, cash flow statements and the Independent Auditor’s Report. This is a standalone financial report for a period shorter than or at the end of a fiscal year, containing full audited financial statements rather than just highlights or an attached Annual Report. It therefore fits the “Interim / Quarterly Report” category (IR). FY 2026
2026-06-04 English
Sattva Sukun Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/06/2026 ,inter alia, to consider and approve Intimation of Board Meeting
Regulatory Filings Classification · 82% confidence The document is an exchange filing under SEBI LODR Regulation 29 notifying the schedule of a board meeting. It contains no actual financial data, audit results, or management changes—only regulatory disclosure of a board meeting date. This is a general compliance announcement to the stock exchange, fitting the “Regulatory Filings” (RNS) category.
2026-05-30 English
Delay in Result
Regulatory Filings Classification · 90% confidence The document is a formal notice to BSE under SEBI (LODR) Regulations informing of a delay in filing audited financial results. It contains no financial data or report itself, and serves as a compliance/regulatory announcement. It does not fit specific categories like Earnings Release or Report Publication Announcement (it neither discloses results nor attaches a report). It falls under the catch-all Regulatory Filings category.
2026-05-30 English
Revised Annual Secretarial Compliance Report
Regulatory Filings Classification · 90% confidence The document is a revised Annual Secretarial Compliance Report submitted under SEBI (LODR) Regulations to the stock exchange by a practicing Company Secretary. It is essentially an attestation/certification of compliance with listing obligations rather than a full financial or management report. It does not contain audited financial statements or constitute the company’s Annual Report or Interim Report. Under the “Certification Rule,” such officer certificates and compliance reports are classified as Regulatory Filings (RNS).
2026-05-30 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.